Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Bellezza

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Thrombosis Research|January 23, 2018
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?Andrea De Giglio, Roberta Porreca, Marta Brambilla, et al.
Genes & Cancer|January 26, 2016
High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosisElena Doldo, Gaetana Costanza, Amedeo Ferlosio, et al.
Cancer|June 30, 2007
Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancerVanesa Gregorc, Anna Spreafico, Irene Floriani, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 24, 2016
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: an experimental studyJacopo Vannucci, Andrea Droghetti, Antonello Bufalari, et al.
Frontiers in Immunology|May 10, 2021
Current Challenges for IDO2 as Target in Cancer ImmunotherapyGiada Mondanelli, Martina Mandarano, Maria Laura Belladonna, et al.
Anticancer Research|June 4, 2020
Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With <sup>18</sup>F-FDG-PET/CTBarbara Palumbo, Rosanna Capozzi, Francesco Bianconi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2015
Future options for ALK-positive non-small cell lung cancerDaniela Iacono, Rita Chiari, Giulio Metro, et al.
The Journal of Nutritional Biochemistry|June 20, 2017
Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E)Desirée Bartolini, Pierangelo Torquato, Carolina Barola, et al.
Oncology and Therapy|January 23, 2022
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the LiteratureSara Baglivo, Martina Mandarano, Guido Bellezza, et al.
Medical Oncology (Northwood, London, England)|April 19, 2018
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinibBiagio Ricciuti, Andrea De Giglio, Carmen Mecca, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Thrombosis Research|January 23, 2018
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?Andrea De Giglio, Roberta Porreca, Marta Brambilla, et al.
Genes & Cancer|January 26, 2016
High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosisElena Doldo, Gaetana Costanza, Amedeo Ferlosio, et al.
Cancer|June 30, 2007
Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancerVanesa Gregorc, Anna Spreafico, Irene Floriani, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 24, 2016
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: an experimental studyJacopo Vannucci, Andrea Droghetti, Antonello Bufalari, et al.
Frontiers in Immunology|May 10, 2021
Current Challenges for IDO2 as Target in Cancer ImmunotherapyGiada Mondanelli, Martina Mandarano, Maria Laura Belladonna, et al.
Anticancer Research|June 4, 2020
Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With <sup>18</sup>F-FDG-PET/CTBarbara Palumbo, Rosanna Capozzi, Francesco Bianconi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2015
Future options for ALK-positive non-small cell lung cancerDaniela Iacono, Rita Chiari, Giulio Metro, et al.
The Journal of Nutritional Biochemistry|June 20, 2017
Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E)Desirée Bartolini, Pierangelo Torquato, Carolina Barola, et al.
Oncology and Therapy|January 23, 2022
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the LiteratureSara Baglivo, Martina Mandarano, Guido Bellezza, et al.
Medical Oncology (Northwood, London, England)|April 19, 2018
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinibBiagio Ricciuti, Andrea De Giglio, Carmen Mecca, et al.
Pageof 11